gms | German Medical Science

16. Jahreskongress für Klinische Pharmakologie

Verbund Klinische Pharmakologie in Deutschland

09. - 10. Oktober 2014, Köln

Endurance sports and analgesics: a prospective cohort study on adverse event incidence and dose dependency

Meeting Abstract

  • presenting/speaker B. Renner - University of Erlangen-Nürnberg Institute of Experimental and Clinical Pharmacology and Toxicology – Erlangen, Deutschland
  • M. Küster - Pain Management Center DGS – Bonn – Bad Godesberg, Deutschland
  • P. Oppel - University of Erlangen-Nürnberg, Department of Orthopedic and Trauma Surgery – Erlangen, Deutschland
  • U. Niederweis - University of Erlangen-Nürnberg Institute of Experimental and Clinical Pharmacology and Toxicology – Erlangen, Deutschland
  • K. Brune - University of Erlangen-Nürnberg Institute of Experimental and Clinical Pharmacology and Toxicology – Erlangen, Deutschland

16. Jahreskongress für Klinische Pharmakologie. Köln, 09.-10.10.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. Doc14vklipha16

doi: 10.3205/14vklipha16, urn:nbn:de:0183-14vklipha169

Veröffentlicht: 25. September 2014

© 2014 Renner et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Aim: Professional and amateur athletes increasingly engage in endurance sports. In order to prevent pain inhibiting their performance, many athletes ingest over-the-counter (OTC) analgesics before competing. We investigated the impact of analgesics on performance and adverse events (AEs) during the Bonn marathon and half marathon races 2010, using an electronic questionnaire which was available online to all participating runners.

Method: Binary logistic regression models were used to calculate the risk of spontaneously reported AEs associated with analgesic use and ingested doses overall, and by various subgroups.

Results: Out of 7,048 participants, 3,913 responded with questionnaires that became the primary study population. Of all respondents, 49% (n=1,931) ingested analgesics before the start of the marathon/half marathon, mostly to prevent pain. Predominantly diclofenac (n=913; 23%) and ibuprofen (n=722; 18%) were used, but other analgesics, including aspirin (n=102; 3%), were also taken.

There was no significant difference between the premature race withdrawal rates in the analgesics cohort and the cohort who did not take analgesics (control group). Race withdrawal due to muscle cramps occurred more often in controls (3% vs 1%, p<0.001). On the other hand, intestinal cramps were more frequently reported in the analgesics cohort to be a reason for withdrawal (2% vs 1%; p<0.01).

The analgesics cohort had a four to ten times higher incidence of each type of AE (gastrointestinal, cardiovascular, and renal AEs; overall incidence 16% vs 4%). The overall risk for analgesic-related AEs was estimated at 5.1 (95% CI 3.9 to 6.7; p<0.001) for unadjusted and 3.0 (95% CI 2.1 to 4.1; p<0.001) for sex, age, exercise (marathon/half marathon) adjusted variables.

Using analgesic dose information, a further adjusted regression model showed a significantly increased risk at rising doses, meaning that increasing the dose (no drug – low dose – high dose) increases the risk of AEs by three times on each step (OR 3.2; 95% CI 2.7 to 4.0; p<0.001).

Conclusion: In conclusion, OTC analgesics taken before endurance sports may cause potentially serious AEs. The incidence of AEs increased with rising dose, but the desired drug effects were not evident.

Note: Study data are published online in [1].


References

1.
Schmidt M, Johannesdottir SA, Lemeshow S, Lash TL, Ulrichsen SP, Bøtker HE, Sørensen HT. Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. BMJ Open. 2013 Apr 29;3(4). pii: e002698. DOI: 10.1136/bmjopen-2013-002698 Externer Link